You are currently viewing a new version of our website. To view the old version click .
Hemato
  • Editorial
  • Open Access

20 March 2020

Recent Advancements in Hematology: Knowledge, Methods and Dissemination

,
,
,
,
,
,
,
,
and
1
Centre for Haemato-Oncology, Barts Cancer Institute, QMUL, London EC1M 6BE, UK
2
Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino, 10133 Turin, Italy
3
Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Via G. Venezian 1, I-20133 Milano, Italy
4
Department of Hematology, Hospital Clinic de Barcelona, Villarroel 170, 08036 Barcelona, Spain
This article belongs to the Collection Exclusive Papers of the Editorial Board Members (EBMs) of Hemato
Communication in the field of biomedical research today involves professionals of numerous backgrounds, including researchers, doctors, public administrators, politicians, and health journalists. Usually, biomedical researchers draw information from their own research data, while all other professionals use information from the scientific literature, institutional press releases, or uncontrolled sources to guide their professional activities and to create public opinion. During this whole process, the view of expert researchers—who act as a filter between biomedical research data and their potential impact on civil society—is missing.
Bloods intends to serve as the voice of a multidisciplinary network of authoritative scientists skilled in the field of hematology. Each quarterly issue of the journal will include a joint editorial authored by the Editor-in-Chief or by the Deputy Editor along with Section Editors. In these editorials, we highlight, in brief reports (of about one hundred words), a number of recently published articles that describe the most recent advancements in hematology. The editorial will be open as a forum with and for readers.
Therefore, the journal will not only publish high-level scientific articles, but will also discuss their significance in the scientific scenario, which includes the transfer of information to the media. Furthermore, for this reason, it is necessary that the sections into which the journal is divided are assigned to the care of a Section Editor. The Section Editor will comment on the application/operational aspect of the research published in the journal.
The Editor-in-Chief will be assisted by one or two Deputy Directors. There will be provisional sections (Non-Neoplastic Blood Disorders; Myeloid Leukemias; Lymphoid Leukemias; Lymphomas; and Plasma Cell Disorders Section), and each will be edited by a Section Editor.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.